Stay updated on Nivolumab for Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Prostate Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A related MedlinePlus Genetics resource about prostate cancer is listed alongside the study’s other educational links.
    Difference
    0.2%
    Check dated 2026-11-15T02:40:29.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The clinical trial record for the ImmunoProst study of nivolumab in prostate cancer is displayed, with details on study design, participant eligibility, locations, and outcome measures.
    Difference
    49%
    Check dated 2026-11-08T05:24:31.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The study record remains unavailable and displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:31:16.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T02:31:00.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T02:19:07.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T03:06:05.000Z thumbnail image

Stay in the know with updates to Nivolumab for Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Prostate Cancer Clinical Trial page.